Cargando…
Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma
Breast implant–associated anaplastic large-cell lymphoma (BIA-ALCL) is a CD30-positive, anaplastic lymphoma kinase–negative T-cell lymphoma. Nearly all cases have been associated with textured implants. Most cases are of effusion-limited, indolent disease, with an excellent prognosis after implant a...
Autores principales: | Turner, Suzanne D., Inghirami, Giorgio, Miranda, Roberto N., Kadin, Marshall E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Investigative Pathology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298558/ https://www.ncbi.nlm.nih.gov/pubmed/31610171 http://dx.doi.org/10.1016/j.ajpath.2019.09.005 |
Ejemplares similares
-
Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research
por: Deva, Anand K., et al.
Publicado: (2020) -
An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
por: Turner, Suzanne D.
Publicado: (2017) -
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma
por: Tabbó, Fabrizio, et al.
Publicado: (2012) -
Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas
por: Merlio, Jean-Philippe, et al.
Publicado: (2021) -
Pathobiology of Anaplastic Large Cell Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2010)